Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jan 26:90:109-112.
doi: 10.1016/j.curtheres.2019.01.006. eCollection 2019.

Global Harmonization of Pediatric Drug Development: Critical for Progress for Developing Safe and Effective Therapeutic Agents for Children

Andrew E Mulberg  1 , Timothy Cripps  1
Affiliations

Global Harmonization of Pediatric Drug Development: Critical for Progress for Developing Safe and Effective Therapeutic Agents for Children

Andrew E Mulberg et al. Curr Ther Res Clin Exp. .

Erratum in

Abstract

The article, "Questionable Industry-Sponsored Studies in Children and Adolescents in Slovenia" provides an opportunity to discuss evolving US and EU legislative measures to improve the available clinical trial-derived pediatric data and provide coherent labeling for pediatric providers in dosing of drugs for children.

Keywords: BPCA; PIP; PREA; Pediatric drug development.

PubMed Disclaimer

References

    1. Rose K, Neubauer D, Grant-Kels J. Questionable Industry-sponsored Studies in Children and Adolescents in Slovenia. Curr Ther Res. 2019 XXX-XXX. - PMC - PubMed
    1. A.E. Mulberg., editor. Pediatric Drug Development: Concepts and Applications. 2nd edition. Wiley; 2013.
    1. Field MJ, Boat TF, editors. Safe and Effective Medicines for Children: Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act. Committee on Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA); Board on Health Sciences Policy; Institute of Medicine. National Academies Press (US); Washington DC: 2012 Feb 29. - PubMed
    1. Shirkey H. Therapeutic orphans. Pediatrics. 1999;104:583–584. - PubMed
    1. Stafford RS. Off-label use of drugs and medical devices: a review of policy implications. Clin Pharmacol Ther. 2012;91:920–925. - PubMed

LinkOut - more resources